tetradecanoylphorbol acetate has been researched along with chrysoeriol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, JX; Bai, L; Chen, YJ; Chou, JY; Fu, XQ; Li, JK; Liu, YX; Wang, YP; Wu, JY; Wu, Y; Wu, ZZ; Yin, CL; Yu, ZL; Zhu, PL | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and chrysoeriol
| Article | Year |
|---|---|
Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Disease Models, Animal; Drug Eruptions; Flavones; Gene Expression Regulation; I-kappa B Proteins; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide Synthase Type II; RAW 264.7 Cells; STAT3 Transcription Factor; Tetradecanoylphorbol Acetate | 2020 |